المؤلفون: Xiaqin Cheng, Jia Liu, Qiongxia Hu, Yingchun Gao, Lin Zhou

المصدر: Frontiers in Oncology, Vol 14 (2024)

مصطلحات موضوعية: secondary ALK mutation, EML4-ALK gene fusion, second-generation ALK-TKIs, Non-small cell lung cancer, case report, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fonc.2024.1430350/full; https://doaj.org/toc/2234-943X

URL الوصول: https://doaj.org/article/8b2f5b92c1a744329a9c0b2bc2d14825

المؤلفون: Yunwei Lu, Zewen Sun, Hao Li, Xiaofeng Chen, Yun Li, Lina Sun, Fan Yang, Guanchao Jiang, Jian Zhou

المصدر: Journal of Cardiothoracic Surgery, Vol 18, Iss 1, Pp 1-5 (2023)

مصطلحات موضوعية: Large-cell neuroendocrine carcinoma, Ground-glass nodule, Volume doubling time, Next-generation sequencing, EML4-ALK gene fusion, Surgery, RD1-811, Anesthesiology, RD78.3-87.3

وصف الملف: electronic resource

Relation: https://doaj.org/toc/1749-8090

URL الوصول: https://doaj.org/article/0fa6635221d34d1ebbf93a3cf9db2b88

المؤلفون: Willem E. Corver, Hans Morreau, Jaap D. H. van Eendenburg, Mehtap Derya Aydemirli, Tom van Wezel, Ellen Kapiteijn, Jan Oosting

المصدر: Endocrine-Related Cancer
Endocrine-Related Cancer, 28(6), 377-389. BIOSCIENTIFICA LTD

مصطلحات موضوعية: 0301 basic medicine, Male, Cancer Research, Lung Neoplasms, Oncogene Proteins, Fusion, Endocrinology, Diabetes and Metabolism, medicine.medical_treatment, Papillary thyroid cancer, Targeted therapy, Iodine Radioisotopes, chemistry.chemical_compound, 0302 clinical medicine, Endocrinology, Carcinoma, Non-Small-Cell Lung, thyroid cancer, Anaplastic lymphoma kinase, Anaplastic Lymphoma Kinase, Thyroid cancer, STAT, personalized medicine, targeted therapy, ERK, Oncology, 030220 oncology & carcinogenesis, Gene Fusion, Lenvatinib, cancer cell line, medicine.drug, Lactams, Macrocyclic, Antineoplastic Agents, 03 medical and health sciences, lorlatinib, Crizotinib, medicine, EML4-ALK gene fusion, ceritinib, cell signaling, Humans, Thyroid Neoplasms, Protein Kinase Inhibitors, Ceritinib, business.industry, Research, AKT, medicine.disease, Lorlatinib, 030104 developmental biology, chemistry, ALK, Cancer research, business

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8eec9b48f10064319208d59f2dcd63c4
http://europepmc.org/articles/PMC8183637

المؤلفون: Sun, Yu, Yang, Fei, Zhou, Xiao-Yan, Zhou, Li-Xin, Li, Xiang-Hong, Lv, Ning, Ying, Jian-Ming, Du, Xiang

المساهمون: Du, X (reprint author), Fudan Univ, Shanghai Canc Ctr, Dept Pathol, 270 Dongan Rd, Shanghai 200032, Peoples R China., Peking Univ, Canc Hosp & Inst, Dept Pathol, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing 100871, Peoples R China., Fudan Univ, Shanghai Canc Ctr, Dept Pathol, 270 Dongan Rd, Shanghai 200032, Peoples R China., Chinese Acad Med Sci, Canc Inst & Hosp, Dept Pathol, Beijing 100730, Peoples R China., Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China., Fudan Univ, Inst Pathol, Shanghai 200433, Peoples R China., Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China.

المصدر: SCI

مصطلحات موضوعية: Non-small cell lung cancer, EML4-ALK gene fusion, immunohistochemistry, fluorescent in situ hybridization, EML4-ALK FUSION TRANSCRIPTS, GENE, ADENOCARCINOMAS, IDENTIFICATION, INHIBITORS, FISH

Relation: INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE.2016,9,(2),2642-2653.; 1398934; http://hdl.handle.net/20.500.11897/438866; WOS:000374655200241

الاتاحة: https://hdl.handle.net/20.500.11897/438866